Yao Wang1, Jian Liu1, Jiandi Xie2, Guoguang Yu1, Qiujing Luo1. 1. Department of Hand and Foot Microsurgery, Yuyao City People's Hospital Yuyao 315400, Zhejiang Province, China. 2. Blood Transfusion Branch, Yuyao City People's Hospital Yuyao 315400, Zhejiang Province, China.
Abstract
OBJECTIVE: This study aimed to explore the therapeutic effect of surgery using platelet-rich plasma combined with a skin flap transplant on open foot fractures with a soft tissue defect. METHODS: From February 2017 to March 2020, 72 patients with open foot fractures and soft tissue defects were recruited as the study cohort. The patients who underwent surgery with just a flap transplant were placed in the control group (the CG) (35 cases), and the patients who underwent surgery using platelet-rich plasma combined with a flap transplant were placed in the research group (the RG) (37 cases). The wound volume changes before and after the treatment, the wound healing times, the fracture healing times, and any adverse prognostic reactions were observed. The pre- and post-treatment VAS and SF-36 scores were observed and recorded. RESULTS: The total effective rate in the RG (100.00%) was significantly higher than the total effective rate in the CG (88.57%) (P=0.034). After the treatment, the wound volumes were lower in both groups, and the volume in the RG was smaller than it was in the CG at 3 weeks and 6 weeks after the treatment (P < 0.05). The average wound healing time in the RG (22.40 ± 2.10 days) was significantly lower than it was in the CG (32.20 ± 3.30 days) (P > 0.05). The average fracture healing time in the RG (6.50 ± 2.20 months) was significantly lower than it was in the RG (7.51 ± 2.33 months) (P > 0.05). The total incidence of adverse reactions to the treatment in the RG was 2.70%, and in the CG it was 11.43%. After the treatment, the VAS scores in the RG were significantly lower than they were in the CG (P < 0.05), and the SF-36 scores in the RG were significantly higher than the SF-36 scores in the CG (P < 0.05). CONCLUSION: Platelet-rich plasma combined with a skin flap transplant can accelerate the healing times of wounds and fractures and lessen the occurrence of adverse reactions during the patients' treatment. AJTR
OBJECTIVE: This study aimed to explore the therapeutic effect of surgery using platelet-rich plasma combined with a skin flap transplant on open foot fractures with a soft tissue defect. METHODS: From February 2017 to March 2020, 72 patients with open foot fractures and soft tissue defects were recruited as the study cohort. The patients who underwent surgery with just a flap transplant were placed in the control group (the CG) (35 cases), and the patients who underwent surgery using platelet-rich plasma combined with a flap transplant were placed in the research group (the RG) (37 cases). The wound volume changes before and after the treatment, the wound healing times, the fracture healing times, and any adverse prognostic reactions were observed. The pre- and post-treatment VAS and SF-36 scores were observed and recorded. RESULTS: The total effective rate in the RG (100.00%) was significantly higher than the total effective rate in the CG (88.57%) (P=0.034). After the treatment, the wound volumes were lower in both groups, and the volume in the RG was smaller than it was in the CG at 3 weeks and 6 weeks after the treatment (P < 0.05). The average wound healing time in the RG (22.40 ± 2.10 days) was significantly lower than it was in the CG (32.20 ± 3.30 days) (P > 0.05). The average fracture healing time in the RG (6.50 ± 2.20 months) was significantly lower than it was in the RG (7.51 ± 2.33 months) (P > 0.05). The total incidence of adverse reactions to the treatment in the RG was 2.70%, and in the CG it was 11.43%. After the treatment, the VAS scores in the RG were significantly lower than they were in the CG (P < 0.05), and the SF-36 scores in the RG were significantly higher than the SF-36 scores in the CG (P < 0.05). CONCLUSION: Platelet-rich plasma combined with a skin flap transplant can accelerate the healing times of wounds and fractures and lessen the occurrence of adverse reactions during the patients' treatment. AJTR
Authors: Rania M El Backly; Samer H Zaky; Anita Muraglia; Laura Tonachini; Francesco Brun; Barbara Canciani; Danilo Chiapale; Federico Santolini; Ranieri Cancedda; Maddalena Mastrogiacomo Journal: Tissue Eng Part A Date: 2012-10-05 Impact factor: 3.845
Authors: M Karayannopoulou; L G Papazoglou; P Loukopoulos; G Kazakos; A Chantes; N Giannakas; I Savvas; D Psalla; M Kritsepi-Konstantinou; D Dionyssiou Journal: Vet Comp Orthop Traumatol Date: 2014-08-04 Impact factor: 1.358
Authors: M Rabillard; J-G Grand; E Dalibert; B Fellah; O Gauthier; G W Niebauer Journal: Vet Comp Orthop Traumatol Date: 2009-10-29 Impact factor: 1.358
Authors: Mara L Schenker; Sarah Yannascoli; Keith D Baldwin; Jaimo Ahn; Samir Mehta Journal: J Bone Joint Surg Am Date: 2012-06-20 Impact factor: 5.284